Development and Characterization of Nanoparticle-Based Drug Delivery Systems for Targeted Therapeutic Applications

Abstract

Nanoparticle-based drug delivery systems have emerged as a promising approach for improving the therapeutic performance of pharmaceutical agents by enhancing drug solubility, stability, bioavailability, and targeted delivery. This study focuses on the development and characterization of a nanoparticle-based delivery system designed to achieve controlled and targeted drug release. The formulation can be prepared using suitable biocompatible polymers or lipid-based materials, followed by evaluation of particle size, polydispersity index, surface charge, drug encapsulation efficiency, drug loading, morphology, and in vitro drug-release characteristics. The influence of formulation variables on nanoparticle properties and drug-release behavior is also assessed. Nanoparticles can facilitate improved drug accumulation at the intended site of action while potentially reducing systemic exposure and unwanted adverse effects. The study highlights the potential of nanotechnology to overcome limitations associated with conventional drug delivery systems and to provide controlled, sustained, and site-specific drug administration. Such systems may contribute to improved therapeutic efficacy and patient outcomes across a range of pharmaceutical and biomedical applications.